News tagged ‘Lymphoma’ clear
"Twinning" U.S.-based and Rwandan physicians in a team approach has shown to improve lymphoma outcomes in children in a country lacking any specialists in children's cancers.
Tags: BasicResearch, ChildhoodCancer, Lymphoma
Dana-Farber researchers found levels of galectin-1, an immunity-related protein, could be the basis of a test, and potentially a targeted treatment for Hodgkin lymphoma.
Tags: TargetedTherapy, Lymphoma
- Castle Connolly Medical Ltd. will recognize George Canellos, MD, an
internationally renowned hematology/oncology expert at Dana Farber
Cancer Institute, for his work in the treatment of advanced Hodgkin's
disease and non-Hodgkin lymphoma.
Tags: Honors, Lymphoma
A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.
Tags: chemotherapy, ChildhoodCancer, Lymphoma
Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.
Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma
- Dana-Farber researchers have found a genetic signature in tumors to help them determine if diffuse large B cell lymphoma patients will benefit more from traditional therapies or targeted therapies.
Tags: BasicResearch, Lymphoma
- Dana-Farber scientists have identified a protein that prevents the
body's immune system from recognizing and attacking Hodgkin lymphoma
cells. Based on this finding, the researchers are now investigating
targeted therapies to disable this molecular "bodyguard" and boost a
patient's ability to fight the blood cancer.
Tags: BasicResearch, ImmuneSystem, Lymphoma
Scientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenström's macroglobulinemia, a rare form of lymphoma that has eluded all previous efforts to find a genetic cause.
Tags: BasicResearch, Lymphoma
- A new Dana-Farber study shows a “big picture” view of an overactive B cell receptor (BCR) signaling pathway that drives about one-third of Diffuse Large B-Cell Lymphomas, which could lead to more promising genetic targets for drug development.
Tags: BasicResearch, Lymphoma
The Leukemia & Lymphoma Society and Dana-Farber joined together to establish the Blood Cancer Research Partnership, an innovative program bringing together a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.
Tags: BasicResearch, Leukemia, Lymphoma